Huibin Zhang
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents 7
- Organic Chemistry top 5%
- Synthesis and biological activity 8
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 22
- Ubiquitin and proteasome pathways 14
- Pharmacological Receptor Mechanisms and Effects 7
- Histone Deacetylase Inhibitors Research 7
- Biochemistry top 10%
-
- Multiple Myeloma Research and Treatments 17
-
- Diabetes Treatment and Management 6
Huibin Zhang
91 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Toxicology 73
- Organic Chemistry 464
- Complementary and alternative medicine 101
- Molecular Biology 774
- Biochemistry 80
Countries citing papers authored by Huibin Zhang
This map shows the geographic impact of Huibin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibin Zhang more than expected).
Fields of papers citing papers by Huibin Zhang
This network shows the impact of papers produced by Huibin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibin Zhang. The network helps show where Huibin Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huibin Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 21 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 33 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 7 | |
| 8 | 2020 | 3 | |
| 9 | 2019 | 52 | |
| 10 | 2019 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 31 | |
| 13 | 2018 | 21 | |
| 14 | 2017 | 14 | |
| 15 | 2012 | 47 | |
| 16 | 2011 | 34 | |
| 17 | 2011 | 9 | |
| 18 | 2010 | 11 | |
| 19 | 2010 | 16 | |
| 20 | 2007 | 65 |
About Huibin Zhang
Huibin Zhang is a scholar working on Toxicology, Hematology and Molecular Biology, having authored 91 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (22 papers), Multiple Myeloma Research and Treatments (17 papers), Ubiquitin and proteasome pathways (14 papers), Synthesis and biological activity (8 papers), Pharmacological Receptor Mechanisms and Effects (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Diabetes Treatment and Management (6 papers). The work is most often cited by research in Toxicology (73 citations), Organic Chemistry (464 citations) and Complementary and alternative medicine (101 citations). Huibin Zhang has collaborated with scholars based in China, United States and Austria. Frequent co-authors include Jinpei Zhou, Wenlong Huang, Xinrui Yuan, Hong Bu, Chao‐Yie Yang, Lingyun Yang, Leilei Zhao, Xiaojun Yang, Wukun Liu and Yifei Yang. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and International Journal of Hydrogen Energy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.